This report on the global drugs of abuse testing market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.
Request For Sample Report at: http://bit.ly/2mFfVDO
The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2015 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global drugs of abuse testing market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global drugs of abuse testing market.
Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of product and product features of different types. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and increasing demand for drug abuse testing in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.
Drugs of Abuse Testing Market: Segmentation
Based on product type, the global drugs of abuse testing market has been segmented three major sub segments namely, analyzers, rapid testing devices and consumables. The analyzers product type segment is further sub – segmented into immunoassay analyzers, chromatographic devices and breath analyzers. The rapid testing devices product type segment is further sub segmented into urine testing devices and oral fluid testing devices. The consumables product type segment is further sub – segmented into fluid collection devices and others. The market has been further studied from the point of view of sample type.
Based on sample type, the market has been segmented into saliva, breath, urine, blood, hair & sweat. On the basis of testing type, the market has been segmented into pain management testing, criminal justice testing and work place screening. Based on the end users the market is categorized into hospitals, diagnostics laboratories, on-the-spot testing and forensic laboratories.
Drugs of Abuse Testing Market: Geographical Outlook
Geographically, the global drugs – of – abuse testing market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, Russia, China, Japan, India, Australia & New Zealand, GCC Countries, South Africa, Brazil, and Mexico.
Browse Complete Report with TOC at: http://www.transparencymarketresearch.com/drugs-abuse-testing-market.html
Key Players Mentioned in the Report are:
The report also profiles major players in the drugs of abuse testing market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Alere Inc., Laboratory Corporation of America Holdings, Roche Diagnostics, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, Siemens Healthcare, Express Diagnostics International Inc. and Shimadzu Corporation.
No comments:
Post a Comment